Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting
ROCHESTER, Minn. -- Mayo Clinic physicians will present findings at the American College of Gastroenterologists Annual Scientific Meeting, Oct. 25-30 in San Antonio. Findings to be presented are: Patients with microscopic colitis do not have reduced risk of developing colon polyps Cross-sectional studies have suggested that patients with microscopic colitis have a lower risk than [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - October 27, 2019 Category: Research Source Type: news
AI is a Big Part of Cleveland Clinic ’s 2019 MIS
CLEVELAND – Two words dominated much of the program agenda for Cleveland Clinic’s 2019 Medical Innovation Summit (MIS) on Tuesday – Artificial Intelligence.
From a keynote address from Craig Mundie, Senior Advisor to the CEO, and former Chief Research and Strategy Officer, Microsoft to a session discussing companies with non-traditional approaches to healthcare, the topic of AI was discussed.
But is AI just the latest fad in healthcare? Is it fully-defined? And are there real-world examples to look to, to see AI in action? Richard Zane, MD CIO of University of Colorado ...
Source: MDDI - October 23, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news
Medtronic Displays its GI Genius at UEG Week
Medtronic is taking some very big steps with artificial intelligence. The Dublin-based company is launching GI Genius – a system it said is the first to use AI to detect colorectal polyps. The product’s launch is taking place during United European Gastroenterology Week in Barcelona, Spain.
GI Genius was developed by Cosmo Pharmaceuticals and has CE mark. Medtronic is bringing the solution to the market through a distribution agreement with the Dublin-based Cosmo Pharmaceuticals.
The GI Genius module uses advanced artificial intelligence to highlight the presence of pre-cancerous lesions...
Source: MDDI - October 18, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news
Breakdown in spawning synchrony: A silent threat to coral persistence
The impacts of human and natural disturbances on coral reefs are typically quantified through visible damage (e.g., reduced coral coverage as a result of bleaching events), but changes in environmental conditions may also cause damage in less visible ways. Despite the current paradigm, which suggests consistent, highly synchronized spawning events, corals that reproduce by broadcast spawning are particularly vulnerable because their reproductive phenology is governed by environmental cues. Here, we quantify coral spawning intensity during four annual reproductive seasons, alongside laboratory analyses at the polyp, colony,...
Source: ScienceNOW - September 4, 2019 Category: Science Authors: Shlesinger, T., Loya, Y. Tags: Anatomy, Morphology, Biomechanics, Ecology r-articles Source Type: news
Nasal Polyps May Increase Risk of Cancer in the Nasal Cavities Nasal Polyps May Increase Risk of Cancer in the Nasal Cavities
Nasal polyps in patients aged 50 and older appear to increase the risk of certain head and neck cancers, suggests a population-based cohort study.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 4, 2019 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
Medical News Today: Physical activity earlier in life prevents colon polyps later on
New research finds that exercising daily in adolescence and adulthood reduces the risk of developing adenomatous polyps at an older age. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 2, 2019 Category: Consumer Health News Tags: Colorectal Cancer Source Type: news
Image of the Day: Expressive Hydra
Researchers track which genes are active in the polyp during successive cell states. (Source: The Scientist)
Source: The Scientist - July 26, 2019 Category: Science Tags: Image of the Day Source Type: news
Stem cell differentiation trajectories in Hydra resolved at single-cell resolution
The adult Hydra polyp continually renews all of its cells using three separate stem cell populations, but the genetic pathways enabling this homeostatic tissue maintenance are not well understood. We sequenced 24,985 Hydra single-cell transcriptomes and identified the molecular signatures of a broad spectrum of cell states, from stem cells to terminally differentiated cells. We constructed differentiation trajectories for each cell lineage and identified gene modules and putative regulators expressed along these trajectories, thus creating a comprehensive molecular map of all developmental lineages in the adult animal. In ...
Source: ScienceNOW - July 24, 2019 Category: Science Authors: Siebert, S., Farrell, J. A., Cazet, J. F., Abeykoon, Y., Primack, A. S., Schnitzler, C. E., Juliano, C. E. Tags: Development, Online Only r-articles Source Type: news
Continuous Anticoagulants + Cold Snare Polypectomy Noninferior
Findings seen among patients with subcentimeter colorectal polyps receiving oral anticoagulants (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 17, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news
Continuous Anticoagulants & #43; Cold Snare Polypectomy Noninferior
WEDNESDAY, July 17, 2019 -- For patients with subcentimeter colorectal polyps receiving oral anticoagulants, continuous administration of anticoagulants (CA) with cold snare polypectomy (CSP) is noninferior to periprocedural heparin bridging (HB)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 17, 2019 Category: Pharmaceuticals Source Type: news
FDA OKs 1st Drug for Sinusitis With Nasal Polyps
Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and chronic rhinosinusitis -- defined as a prolonged inflammation of the sinuses and nasal cavity, the FDA said. (Source: WebMD Health)
Source: WebMD Health - June 27, 2019 Category: Consumer Health News Source Type: news
FDA Approves First Drug for Sinusitis With Nasal Polyps, Dupixent (Dupilumab)
THURSDAY, June 27, 2019 -- In what specialists say could be a turning point in care, the U.S. Food and Drug Administration on Wednesday approved the first drug to treat chronic sinusitis that involves the growth of polyps within the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 27, 2019 Category: General Medicine Source Type: news
FDA Approves First Drug for Sinusitis With Nasal Polyps
Title: FDA Approves First Drug for Sinusitis With Nasal PolypsCategory: Health NewsCreated: 6/27/2019 12:00:00 AMLast Editorial Review: 6/27/2019 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - June 27, 2019 Category: Allergy & Immunology Source Type: news
FDA OKs First Treatment for Chronic Rhinosinusitis With Polyps FDA OKs First Treatment for Chronic Rhinosinusitis With Polyps
Dupilumab is the first treatment approved for inadequately controlled chronic rhinosinusitis with nasal polyps.FDA Approvals (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - June 26, 2019 Category: Universities & Medical Training Tags: Allergy & Clinical Immunology News Alert Source Type: news
New approval for Dupixent could help propel it to blockbuster status
The FDA has given Dupixent the go-ahead as a treatment for nasal polyps. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 26, 2019 Category: Pharmaceuticals Source Type: news
